Approaches to manage 'affordability' of high budget impact medicines in key EU countries Approaches to manage 'affordability' of high budget impact medicines in key EU countries (original) (raw)

Approaches to manage 'affordability' of high budget impact medicines in key EU countries

Nicolas Touchot

Journal of market access & health policy, 2018

View PDFchevron_right

Fair Pricing of Innovative Medicines: An EHA Position Paper

John Gribben

HemaSphere, 2020

View PDFchevron_right

Affordability of medicines in the European Union

Elzbieta Nowakowska

PloS one, 2017

View PDFchevron_right

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

Guenka Petrova

Frontiers in Public Health

View PDFchevron_right

Defining and Measuring the Affordability of New Medicines: A Systematic Review

Paul Overton

PharmacoEconomics, 2017

View PDFchevron_right

Pharmaceutical Pricing in Europe: Weighing up the Options

Elias Mossialos

International Social Security Review, 2006

View PDFchevron_right

AFFORDABILITY OF MEDICINES AND DIAGNOSTICS

Tamas Bereczky

View PDFchevron_right

Valorising and Creating Access to Innovative Medicines in the European Union

Steven Simoens

Frontiers in Pharmacology, 2011

View PDFchevron_right

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future

Newman Madzikwa

Frontiers in Pharmacology, 2016

View PDFchevron_right

Cost-Containment Policies in Public Pharmaceutical Spending in the EU

Giuseppe Carone

SSRN Electronic Journal, 2000

View PDFchevron_right

From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries

Reinhard Busse

Health research policy and systems / BioMed Central, 2015

View PDFchevron_right

Fighting Excessive Pharmaceutical Prices: Evaluating the Options

ANDRE DEN EXTER

European Journal of Health Law, 2020

View PDFchevron_right

Value-based drug price schemes: a welfare analysis

Rosella Levaggi

Journal of Pharmaceutical Health Services Research, 2021

View PDFchevron_right

A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing

Ulf Persson

Applied Health Economics and Health Policy, 2012

View PDFchevron_right

Economic Evaluation for Pricing and Reimbursement of New Drugs in Spain: Fable or Desideratum?

José A Sacristán

Value in Health, 2020

View PDFchevron_right

Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market

Davor Mance

Croatian Medical Journal, 2016

View PDFchevron_right

Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies

Fatima Suleman

Journal of Pharmaceutical Policy and Practice, 2019

View PDFchevron_right

The consequences of greater net price transparency for innovative medicines in Europe: Searching for a consensus

Pius Gyger

2020

View PDFchevron_right

Application of the Price-Volume Approach in Cases of Innovative Drugs Where Value-Based Pricing is Inadequate: Description of Real Experiences in Italy

Andrea Messori

Clinical drug investigation, 2016

View PDFchevron_right

Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways

Silvia Cammarata

Clinical pharmacology and therapeutics, 2016

View PDFchevron_right

Cost Containment Measures for Pharmaceuticals Expenditure in the EU Countries: A Comparative Analysis

Wim Groot

The Open Health Services and Policy Journal, 2009

View PDFchevron_right

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment

Bengt Jonsson

The European Journal of Health Economics, 2011

View PDFchevron_right

Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?

Claudio Jommi

Journal of Pharmaceutical Policy and Practice, 2021

View PDFchevron_right

COVID-19 and the global public health: Tiered pricing of pharmaceutical drugs as a price-reducing policy tool

Muhammad Abbas

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

View PDFchevron_right